EPISODE · Nov 26, 2024 · 29 MIN
Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
from Keeping Current CME
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts? Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
0:00
29:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 29 minutes long.
When was this Keeping Current CME episode published?
This episode was published on November 26, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!